Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
Indirectly affected
- XLF Financial Select Sector SPDR
Financial Select Sector SPDR holds the financials sector that The Goldman Sachs Group belongs to, so it often moves with news about it.
- MS Morgan Stanley
Morgan Stanley is a peer of The Goldman Sachs Group in security brokers, dealers and flotation companies; rivals often move on the same news.
- BLK BlackRock
BlackRock is a peer of The Goldman Sachs Group in security brokers, dealers and flotation companies; rivals often move on the same news.
- SCHW The Charles Schwab
The Charles Schwab is a peer of The Goldman Sachs Group in security brokers, dealers and flotation companies; rivals often move on the same news.
- IBKR Interactive Brokers Group
Interactive Brokers Group is a peer of The Goldman Sachs Group in security brokers, dealers and flotation companies; rivals often move on the same news.
- HOOD Robinhood Markets
Robinhood Markets is a peer of The Goldman Sachs Group in security brokers, dealers and flotation companies; rivals often move on the same news.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Moderna belongs to, so it often moves with news about it.
- AMGN Amgen
Amgen is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GS | +1.48% | +3.20% | base | -0.32% | +3.30% | -3.36% | -3.65% |
| MRNA | -5.90% | +0.84% | base | +3.40% | +16.98% | +9.28% | +19.24% |
| XLF | -2.88% | -1.05% | base | -0.63% | +2.83% | +0.10% | -0.41% |
| MS | +0.66% | +2.30% | base | +0.19% | +4.43% | -1.77% | -2.33% |
| BLK | -2.68% | +0.76% | base | -0.55% | +4.89% | +0.30% | +1.00% |
| SCHW | +0.63% | +0.83% | base | +0.60% | +5.22% | +4.34% | +3.10% |
| IBKR | +9.91% | +9.27% | base | +3.47% | +4.07% | -2.84% | +1.30% |
| HOOD | +12.89% | +9.25% | base | +2.21% | +4.33% | -6.44% | -3.47% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| AMGN | -3.75% | -1.04% | base | -0.92% | +2.72% | -1.06% | -0.89% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | -0.92% | final price |
| AMGN | the next day | +2.72% | final price |
| AMGN | two days later | -1.06% | final price |
| AMGN | three days later | -0.89% | final price |
| AMGN | three days earlier | -1.04% | final price |
| AMGN | five days earlier | -3.75% | final price |
| BLK | that day | -0.55% | final price |
| BLK | the next day | +4.89% | final price |
| BLK | two days later | +0.30% | final price |
| BLK | three days later | +1.00% | final price |
| BLK | three days earlier | +0.76% | final price |
| BLK | five days earlier | -2.68% | final price |
| GS | that day | -0.32% | final price |
| GS | the next day | +3.30% | final price |
| GS | two days later | -3.36% | final price |
| GS | three days later | -3.65% | final price |
| GS | three days earlier | +3.20% | final price |
| GS | five days earlier | +1.48% | final price |
| HOOD | that day | +2.21% | final price |
| HOOD | the next day | +4.33% | final price |
| HOOD | two days later | -6.44% | final price |
| HOOD | three days later | -3.47% | final price |
| HOOD | three days earlier | +9.25% | final price |
| HOOD | five days earlier | +12.89% | final price |
| IBKR | that day | +3.47% | final price |
| IBKR | the next day | +4.07% | final price |
| IBKR | two days later | -2.84% | final price |
| IBKR | three days later | +1.30% | final price |
| IBKR | three days earlier | +9.27% | final price |
| IBKR | five days earlier | +9.91% | final price |
| MRNA | that day | +3.40% | final price |
| MRNA | the next day | +16.98% | final price |
| MRNA | two days later | +9.28% | final price |
| MRNA | three days later | +19.24% | final price |
| MRNA | three days earlier | +0.84% | final price |
| MRNA | five days earlier | -5.90% | final price |
| MS | that day | +0.19% | final price |
| MS | the next day | +4.43% | final price |
| MS | two days later | -1.77% | final price |
| MS | three days later | -2.33% | final price |
| MS | three days earlier | +2.30% | final price |
| MS | five days earlier | +0.66% | final price |
| SCHW | that day | +0.60% | final price |
| SCHW | the next day | +5.22% | final price |
| SCHW | two days later | +4.34% | final price |
| SCHW | three days later | +3.10% | final price |
| SCHW | three days earlier | +0.83% | final price |
| SCHW | five days earlier | +0.63% | final price |
| XLF | that day | -0.63% | final price |
| XLF | the next day | +2.83% | final price |
| XLF | two days later | +0.10% | final price |
| XLF | three days later | -0.41% | final price |
| XLF | three days earlier | -1.05% | final price |
| XLF | five days earlier | -2.88% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Goldman Sachs Group (GS), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Michael Rulli bought Goldman Sachs Group (GS), worth $1,001 - $15,000 on 3 Sep 2026. That is 61 days before publication. Filed 2 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Goldman Sachs Group (GS), worth $1,001 - $15,000 on 26 Aug 2026. That is 69 days before publication. Filed 10 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 14 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold Interactive Brokers Group (IBKR), worth $50,001 - $100,000 on 21 Aug 2026. That is 74 days before publication. Filed 8 Oct 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 19 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 42 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 69 days before publication. Filed 5 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Goldman Sachs reiterates Neutral on Moderna stock, $137 target ahead of earnings” scores 12 out of 100. The score uses 1 sources.